Anosmia
📧 Sign up to get email alerts when something new happens for Anosmia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: COVID-19 Anosmia Study [Phase 2]
Phase 2 clinical trial update on COVID-19-related anosmia completed, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-11-16Clinical Trial Update: Olfactory Disfunction and Co-ultraPEALut [Phase 4]
Phase 4 clinical trial update on olfactory dysfunction (anosmia) related to COVID-19 evaluating Co-ultraPEALut.
-
CLINICAL_TRIALS trial_result · 2022-07-18Clinical Trial Update: Intranasal Insulin for COVID-19-related Smell Loss [Phase 3]
Phase 3 trial evaluating intranasal insulin for COVID-19-related smell loss has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Role of Ivermectin Nanosuspension as Nasal Spray in Treatment of Persistant Post covid19 Anosmia [Phase 2, Phase 3]
A clinical trial update on an ivermectin nanosuspension nasal spray for persistent post-COVID-19 anosmia, currently in Phase 2/Phase 3 with …
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN) [Phase 2]
Phase 2 trial evaluating hesperidin therapy for COVID-19–related symptoms has completed; results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Smell Changes & Efficacy of Nasal Theophylline [Phase 2]
Phase 2 trial evaluating nasal theophylline for olfactory disorders/anosmia; completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-25Clinical Trial Update: Effectiveness and Safety of Platelet Rich Plasma (PRP) on Persistent Olfactory Dysfunction Related to COVID-19 [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluated the effectiveness and safety of platelet-rich plasma (PRP) for persistent olfactory dysfunction r…
-
CLINICAL_TRIALS trial_result · 2021-10-26Clinical Trial Update: Clinical Assessment of Insulin Fast Dissolving Film in Treatment of Post Infection Anosmia [Phase 2]
Phase 2 clinical trial assessing an insulin fast-dissolving film for treatment of post-infection anosmia has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: BNO 1030 Extract (Imupret) in the Treatment of Mild Forms of COVID-19 [Phase 4]
Phase 4 trial assessing BNO 1030 Extract (Imupret) for mild COVID-19; study completed.
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: NAC for Head Trauma-induced Anosmia [Phase 3]
Phase 3 trial of NAC for anosmia due to head trauma; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Corticosteroid Nasal Spray in COVID-19 Anosmia [Phase 3]
Phase 3 trial update on a corticosteroid nasal spray for COVID-19-related anosmia has completed.
-
CLINICAL_TRIALS trial_result · 2018-03-20Clinical Trial Update: NAC Trial for Anosmia [EARLY_Phase 1]
An early-phase (Phase 1) trial evaluating N-acetylcysteine for anosmia has completed. The study was sponsored by the University of Miami.
-
CLINICAL_TRIALS trial_result · 2007-01-19Clinical Trial Update: A Study of the Effects of Sodium Citrate on Olfactory Thresholds
A clinical trial is studying whether sodium citrate affects olfactory threshold in patients with loss or reduced sense of smell. The study's…